[Evaluation of combined radiotherapy of gastric carcinoma].
Combined radiotherapy with chemotherapy was performed on 82 patients with advanced gastric carcinoma (T2-T4: M0). A small target volume, including the primary lesion and regional lymph nodes (N1), was irradiated with the dose of 60 Gy. The survival rate was 21% at two years and 6% at five. The prognosis was better in cases of less advanced carcinoma, types I and II carcinoma and radioresponsive tumor. As the conclusion, it was suggested that this combination therapy could be curative in a few patients and be valuable to prolong the life of some others.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011882:Radiotherapy, High-Energy; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D005641:Tegafur / Q000008:administration & dosage
D005641:Tegafur; C017367:carmofur; D005472:Fluorouracil